Literature DB >> 9525361

Impairment of health and quality of life in people with large waist circumference.

M E Lean1, T S Han, J C Seidell.   

Abstract

BACKGROUND: Symptoms and secondary disorders associated with excess central fat distribution are being increasingly recognised. We aimed to define the symptoms and assess risks of chronic disorders in people with large waist circumferences.
METHODS: We did a cross-sectional study of 5887 men and 7018 women aged 20-59 years from the general population of Maastricht, Amsterdam, and Doetinchem, Netherlands. We assessed in health centres respiratory insufficiency, low back pain, degree of physical function, presence of non-insulin-dependent diabetes, and cardiovascular risk factors. We measured bodyweight, body-mass index, and waist circumference by action levels (men: less than action level 1 <94.0 cm, action levels 1-2 94.0-101.9 cm, more than action level 2 > or =102.0 cm; women: less than action level 1 <80.0 cm, action levels 1-2 80.0-87.9 cm) more than action level 2 > or =88.0 cm). The reference group were people with waist circumferences lower than action level 1.
FINDINGS: All symptoms and risks increased among participants higher than action level 2, after adjustment for age and lifestyle, by 3.1 (95% CI 2.5-3.7) in men and 2.7 (2.3-3.1) in women for shortness of breath when walking upstairs; 4.5 (2.5-7.8) and 3.8 (1.9-7.3) for non-insulin-dependent diabetes; and 4.2 (3.6-5.0) and 2.8 (2.4-3.2) for at least one major cardiovascular risk factor. Above action level 2, compared with the reference group, men and women were at twice the risk of difficulties in everyday activities, women were 1.5 times more likely to have low back pain or symptoms of intervertebral disc herniation, with secondary problems including hindrance to daily activities.
INTERPRETATION: People with large waist circumferences have excess burden of ill health. Waist action levels could be useful for health promotion to raise awareness of the need for weight management.

Entities:  

Mesh:

Year:  1998        PMID: 9525361     DOI: 10.1016/s0140-6736(97)10004-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  66 in total

Review 1.  Prevalence and time trends of obesity in Europe.

Authors:  J C Seidell
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

Review 2.  Cardiovascular risks in obesity.

Authors:  E C Uchegbu; P G Kopelman
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

Review 3.  The obesity epidemic: can we turn the tide?

Authors:  I Campbell
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

4.  Risk factors associated with chronic low back pain in Syria.

Authors:  Mohammad Salem Alhalabi; Hassan Alhaleeb; Sarah Madani
Journal:  Avicenna J Med       Date:  2015 Oct-Dec

Review 5.  ABC of obesity. Assessment of obesity and its clinical implications.

Authors:  Thang S Han; Naveed Sattar; Mike Lean
Journal:  BMJ       Date:  2006-09-30

6.  Obesity: a modern epidemic.

Authors:  Arthur H Rubenstein
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

7.  Rise and fall of anti-obesity drugs.

Authors:  Ming-Fang Li; Bernard My Cheung
Journal:  World J Diabetes       Date:  2011-02-15

Review 8.  Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism.

Authors:  Eliza B Geer; Julie Islam; Christoph Buettner
Journal:  Endocrinol Metab Clin North Am       Date:  2014-03       Impact factor: 4.741

9.  Pharmacotherapy for obesity.

Authors:  Mingfang Li; Bernard M Y Cheung
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

10.  Influences of body mass index and waist circumference on physical function in older persons with heart failure.

Authors:  Stephanie A Prince; Ian Janssen; Joan E Tranmer
Journal:  Can J Cardiol       Date:  2008-12       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.